About ARK Genomic Revolution ETF
The ARK Genomic Revolution ETF (ARKG) is an actively managed exchange-traded fund that seeks long-term growth of capital through investing in companies that are relevant to the fund’s theme of genomics revolution. Companies within the ETF are focused on enhancing the quality of human life by incorporating genomic and scientific advancements into their business, working in the fields of targeted therapeutics, the gene-editing technology known as CRISPR, bioinformatics, stem cell technology, molecular diagnostics, and agricultural biology. The fund, founded in 2014, has an expense ratio of 0.75% and net assets worth $8.5bn. Top-weighted holdings of ARKG include Pacific Biosciences of California, Vertex Pharmaceuticals, Teladoc Health, Accolade, Fate Therapeutics, and Twist Bioscience. Start spread betting or trading CFDs on our ARK Genomic Revolution ETF price.
Constituent weightings
Component |
Weighting |
1 Day |
1 Month |
3 Month |
Why trade ARK Genomic Revolution ETF with CMC Markets?
We've invested over £100m into our trading platform, creating pioneering technology that puts powerful software in your hands.
-
One-click trading
Set your default position size and enter with a single 'click'.
-
99.9% fill rate with 0.0029s execution*
Wherever possible we fill your trade and always at the price you see.
-
99.95%+ platform stability**
We consistently achieve core platform uptime, allowing you to focus on your trading.
-
Precise pricing
We crunch 225m prices every day, from up to 14 feeds from tier one liquidity providers.
Related news